Sytrinol® - Research Studies

To date, three main studies have been carried out to investigate Sytrinol’s effects on high cholesterol levels. The first study involved 60 participants with raised cholesterol levels. After taking 300/mg of Sytrinol each day for four weeks, those who participated had lowered total cholesterol by 25%, bad LDL cholesterol by 19%, and triglycerides by 24%.

In a second, smaller study, 10 subjects with elevated cholesterol levels benefited after four weeks of treatment with 300/mg of Sytrinol per day. In this study, Sytrinol therapy lowered total cholesterol levels by 20%, LDL cholesterol by 22%, apolipoprotein B (a component of LDL) by 21%, and triglycerides by 28%. Participants also had a significant 5% increase in Apolipoprotein A1, an important structural protein of the good HDL cholesterol.

Researchers recently completed a third clinical trial, a 12-week placebo-controlled study involving 120 men and women with moderately elevated cholesterol levels. Compared to those in the placebo group, subjects taking Sytrinol had a 30% drop in total cholesterol, 27% in LDL cholesterol, and 34% in triglycerides. In addition, HDL levels increased by 4%, resulting in a significant 29% improvement in the LDL:HDL ratio.

It should be noted that during clinical trials, Sytrinol worked independent of diet changes. Toxicity studies have shown that Sytrinol is well tolerated, with no toxic effects following consumption of up to 1% of total dietary intake, or the equivalent of a 150-pound person consuming almost 14 grams per day—that’s nearly 50 times the recommended daily dosage of 300 mg/day.

Effect of Citrus Flavonoids and Tocotrienols on Serum Cholesterol Levels in Hypercholesterolemic Subjects

All patents and trademarks associated with Sytrinol® are the exclusive property of KGK Synergize Inc.

TOP ^